A new generation of implantable electrodes
Therapeutic outcomes from clinical neural implants are limited by their mechanical properties. Their stiff and rigid designs present a mechanical mismatch compared to the soft and curved tissues they interface with, thereby constraining the physiological motion dynamics of the nervous system.
At Neurosoft Bioelectronics, we are addressing this issue by engineering elasticity in thin film materials to manufacture implantable electrodes that are much softer and flexible, and that can seamlessly interface with the nervous system.
Latest News
Neurosoft Bioelectronics wins the final stage of Venture Kick
We are very pleased to announce that Neurosoft Bioelectronics has won the highest stage of Venture Kick and received a final round of funding for a total of 150 000 CHF. The Venture Kick jury has selected our project to receive the final “kick”, supporting us in the...
Neurosoft Bioelectronics is one of the 8 Prix Strategis semi-finalists!
We are proud to announce that Neurosoft Bioelectronics has been selected as one of the 8 semi-finalist startups competing for the Prix Strategis 2021. The Jury has selected our project out of 111 promising applicants. The next step will be a meeting with students from...
Welcome to Karsten Bagger – new Chief Business Officer (CBO)
We are happy to announce that Karsten Bagger has joined Neurosoft Bioelectronics as its Chief Business Officer (CBO).Karsten has a MSc in Finance, he previously worked at UBS as an investment strategist and over the past 6 years, he has mainly headed up medtech...
Supported by
